Wong; Michael K.C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wong; Michael K.C..The latest application filed is for "inhibitors of irak4 activity".

Company Profile

0.28.24

Wong; Michael K.C. - Somerset NJ
WONG; Michael K.C. - US
Wong; Michael K. C. - North Brunswick NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors of IRAK4 activity Grant 9,598,440 - Seganish , et al. March 21, 2	2017-03-21
Inhibitors Of Irak4 Activity App 20150299224 - SEGANISH; W. MICHAEL ; et al.	2015-10-22
Compounds for the treatment of inflammatory disorders Grant 8,859,529 - Shankar , et al. October 14, 2	2014-10-14
Compounds for the treatment of inflammatory disorders Grant 8,569,336 - Tong , et al. October 29, 2	2013-10-29
Compounds for the treatment of inflammatory disorders Grant 8,541,572 - Kozlowski , et al. September 24, 2	2013-09-24
Compounds for the treatment of inflammatory diseases Grant 8,450,355 - Wong , et al. May 28, 2	2013-05-28
Spiro-imidazolone derivatives as glucagon receptor antagonists Grant 8,361,959 - Stamford , et al. January 29, 2	2013-01-29
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 8,207,170 - Kim , et al. June 26, 2	2012-06-26
Compounds for the treatment of inflammatory disorders Grant 8,178,553 - Lavey , et al. May 15, 2	2012-05-15
Compounds For The Treatment Of Inflammatory Disorders App 20120015926 - Tong; Ling ; et al.	2012-01-19
Compounds For The Treatment Of Inflammatory Disorders App 20120010181 - Kozlowski; Joseph A. ; et al.	2012-01-12
Compounds For The Treatment Of Inflammatory Diseases App 20110288077 - Wong; Michael K.C. ; et al.	2011-11-24
Compounds For The Treatment Of Inflammatory Disorders App 20110288054 - Shankar; Bandarpalle B. ; et al.	2011-11-24
Spiro-imidazolone Derivatives As Glucagon Receptor Antagonists App 20110178007 - Stamford; Andrew ; et al.	2011-07-21
Heterocyclic Substituted Piperazines With Cxcr3 Antagonist Activity App 20110065651 - Kim; Seong Heon ; et al.	2011-03-17
Compounds for the treatment of inflammatory disorders Grant 7,879,890 - Yu , et al. February 1, 2	2011-02-01
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity Grant 7,879,838 - Zeng , et al. February 1, 2	2011-02-01
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,868,005 - Rosenblum , et al. January 11, 2	2011-01-11
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 7,868,006 - Kim , et al. January 11, 2	2011-01-11
Compounds for the treatment of inflammatory disorders Grant 7,772,263 - Lavey , et al. August 10, 2	2010-08-10
Compounds For The Treatment Of Inflammatory Disorders App 20100120838 - Lavey; Brian J. ; et al.	2010-05-13
Compounds for the treatment of inflammatory disorders Grant 7,687,527 - Yu , et al. March 30, 2	2010-03-30
Compounds for the treatment of inflammatory disorders Grant 7,683,088 - Lavey , et al. March 23, 2	2010-03-23
Compounds for the treatment of inflammatory disorders Grant 7,683,085 - Yu , et al. March 23, 2	2010-03-23
Cannabinoid receptor ligands Grant 7,645,774 - Friary , et al. January 12, 2	2010-01-12
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,566,718 - Wong , et al. July 28, 2	2009-07-28
Compounds For The Treatment Of Inflammatory Disorders App 20090170875 - Yu; Wensheng ; et al.	2009-07-02
Compounds For The Treatment Of Inflammatory Disorders App 20090156586 - Lavey; Brian J. ; et al.	2009-06-18
Compounds For The Treatment Of Inflammatory Disorders App 20090137586 - Yu; Wensheng ; et al.	2009-05-28
Compounds For The Treatment Of Inflammatory Disorders App 20090111803 - Yu; Wensheng ; et al.	2009-04-30
Compounds for the treatment of inflammatory disorders Grant 7,524,842 - Lavey , et al. April 28, 2	2009-04-28
Compounds for the treatment of inflammatory disorders Grant 7,504,424 - Yu , et al. March 17, 2	2009-03-17
Compounds for the treatment of inflammatory disorders Grant 7,488,745 - Yu , et al. February 10, 2	2009-02-10
Compounds for the treatment of inflammatory disorders Grant 7,482,370 - Yu , et al. January 27, 2	2009-01-27
Compounds for the treatment of inflammatory disorders App 20070265299 - Lavey; Brian J. ; et al.	2007-11-15
Compounds for the treatment of inflammatory disorders App 20070219218 - Yu; Wensheng ; et al.	2007-09-20
Compounds for the treatment of inflammatory disorders App 20070197564 - Lavey; Brian J. ; et al.	2007-08-23
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20070054919 - Rosenblum; Stuart B. ; et al.	2007-03-08
Compounds for the treatment of inflammatory disorders App 20060276506 - Yu; Wensheng ; et al.	2006-12-07
Heterocyclic substituted piperazines with CXCR3 antagonist activity App 20060276479 - Kim; Seong Heon ; et al.	2006-12-07
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20060276480 - Wong; Michael K. C. ; et al.	2006-12-07
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity App 20060276448 - Zeng; Qingbei ; et al.	2006-12-07
Compounds for the treatment of inflammatory disorders App 20060205797 - Yu; Wensheng ; et al.	2006-09-14
Cannabinoid receptor ligands Grant 7,071,213 - Friary , et al. July 4, 2	2006-07-04
Cannabinoid receptor ligands App 20050282861 - Friary, Richard J. ; et al.	2005-12-22
Cannabinoid receptor ligands App 20040010013 - Friary, Richard J. ; et al.	2004-01-15